U.S. markets closed

Global Medical REIT Inc. (GMRE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
13.82+0.13 (+0.95%)
At close: 4:00PM EDT

13.69 -0.12 (-0.90%)
After hours: 5:24PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close13.69
Bid13.79 x 800
Ask13.80 x 1000
Day's Range13.57 - 13.82
52 Week Range8.56 - 14.84
Avg. Volume539,503
Market Cap840.176M
Beta (5Y Monthly)-7.33
PE Ratio (TTM)N/A
EPS (TTM)-0.17
Earnings DateMar 04, 2021
Forward Dividend & Yield0.82 (5.96%)
Ex-Dividend DateMar 31, 2021
1y Target Est15.81
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
25% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Are Insiders Buying Global Medical REIT Inc. (NYSE:GMRE) Stock?
    Simply Wall St.

    Are Insiders Buying Global Medical REIT Inc. (NYSE:GMRE) Stock?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...

  • Outlook Brightens for Adobe Shares

    Outlook Brightens for Adobe Shares

    A revived economy should spur demand for its revenue-enhancing products. Also, Wall Street opinions on Cowen, Global Medical REIT, Alcon, RH, and KB Home

  • Business Wire

    Global Medical REIT Inc. Announces Pricing of Public Offering of Common Stock

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company") today announced that it has priced an underwritten public offering (the "Offering") of 7,500,000 shares of its common stock, par value $0.001 per share, at a price to the public of $13.30 per share for gross proceeds of $99,750,000, before deducting underwriting discounts and commissions and offering expenses payable by the Company. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock. The Company intends to use the net proceeds from the Offering to repay a portion of the outstanding indebtedness under its credit facility, to fund acquisitions and for other general corporate purposes.